Biomerica Inc (BMRA):企業の製品パイプライン分析

◆英語タイトル:Biomerica Inc (BMRA) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME1309PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥171,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥256,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biomerica, Inc. (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits used to analyze blood, urine and fecal specimens of the patient to diagnose various diseases and medical complications. It focuses on the development of products for diabetes, gastrointestinal, food intolerances and esoteric tests by utilizing enzyme immunoassay technology. Biomerica’s diagnostic tests are used by hospitals, clinical laboratories, physician’s offices, and consumers around the world. The company distributes products in Americas, Europe, Asia and the Middle East. Biomerica is headquartered in Irvin, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biomerica Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Biomerica Inc Company Overview
Biomerica Inc Company Snapshot
Biomerica Inc Pipeline Products and Ongoing Clinical Trials Overview
Biomerica Inc – Pipeline Analysis Overview
Business Description
Biomerica Inc – Key Facts
Biomerica Inc – Major Products and Services
Biomerica Inc Pipeline Products by Development Stage
Biomerica Inc Ongoing Clinical Trials by Trial Status
Biomerica Inc Pipeline Products Overview
HP Detect H. Pylori Test
HP Detect H. Pylori Test Product Overview
InFoods – Crohn’s Disease
InFoods – Crohn’s Disease Product Overview
InFoods – Functional Dyspepsia
InFoods – Functional Dyspepsia Product Overview
InFoods – Gastroesophageal Reflux Disease
InFoods – Gastroesophageal Reflux Disease Product Overview
InFoods – Ulcerative Colitis
InFoods – Ulcerative Colitis Product Overview
InFoods IBS
InFoods IBS Product Overview
InFoods IBS Clinical Trial
Rapid IgG/IgM Test – COVID-19
Rapid IgG/IgM Test – COVID-19 Product Overview
Serological ELISA Test – COVID-19
Serological ELISA Test – COVID-19 Product Overview
Biomerica Inc – Key Competitors
Biomerica Inc – Key Employees
Biomerica Inc – Key Employee Biographies
Biomerica Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biomerica Inc, Recent Developments
Jan 07, 2020: Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods irritable bowel syndrome (IBS) diagnostic guided therapy clinical trial
Oct 16, 2019: Biomerica reports 1st quarter fiscal 2020 financials
Aug 30, 2019: Biomerica announces fiscal year end 2019 financial results
Aug 21, 2019: Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
Jun 05, 2019: Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million
Apr 16, 2019: Biomerica announces third quarter financial results
Apr 08, 2019: Biomerica announces Notice of Allowance for new U.S. Patent application covering diagnostic guided therapy for irritable bowel syndrome (IBS)
Feb 05, 2019: Biomerica announces updates for H. Pylori clinical studies
Jan 15, 2019: Biomerica announces second quarter financial results
Oct 16, 2018: Biomerica announces 1st Quarter Fiscal 2019 Financials
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Biomerica Inc Pipeline Products and Ongoing Clinical Trials Overview
Biomerica Inc Pipeline Products by Equipment Type
Biomerica Inc Pipeline Products by Indication
Biomerica Inc Ongoing Clinical Trials by Trial Status
Biomerica Inc, Key Facts
Biomerica Inc, Major Products and Services
Biomerica Inc Number of Pipeline Products by Development Stage
Biomerica Inc Pipeline Products Summary by Development Stage
Biomerica Inc Ongoing Clinical Trials by Trial Status
Biomerica Inc Ongoing Clinical Trials Summary
HP Detect H. Pylori Test - Product Status
HP Detect H. Pylori Test - Product Description
InFoods - Crohn’s Disease - Product Status
InFoods - Crohn’s Disease - Product Description
InFoods - Functional Dyspepsia - Product Status
InFoods - Functional Dyspepsia - Product Description
InFoods - Gastroesophageal Reflux Disease - Product Status
InFoods - Gastroesophageal Reflux Disease - Product Description
InFoods - Ulcerative Colitis - Product Status
InFoods - Ulcerative Colitis - Product Description
InFoods IBS - Product Status
InFoods IBS - Product Description
InFoods IBS - Endpoint Determination Study for an Antibody Guided Dietary Restriction Trial Using Biomerica InFoods IBS Test in Patients with a Previous Diagnosis of Irritable Bowel Syndrome (IBS)
Rapid IgG/IgM Test - COVID-19 - Product Status
Rapid IgG/IgM Test - COVID-19 - Product Description
Serological ELISA Test - COVID-19 - Product Status
Serological ELISA Test - COVID-19 - Product Description
Biomerica Inc, Key Employees
Biomerica Inc, Key Employee Biographies
Biomerica Inc, Subsidiaries
Glossary

★海外企業調査レポート[Biomerica Inc (BMRA):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Danone SA:企業の戦略・SWOT・財務情報
    Danone SA - Strategy, SWOT and Corporate Finance Report Summary Danone SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • AGF Management Ltd:企業の戦略・SWOT・財務分析
    AGF Management Ltd - Strategy, SWOT and Corporate Finance Report Summary AGF Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務情報
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Novadaq Technologies Inc. (NDQ)-医療機器分野:企業M&A・提携分析
    Summary Novadaq Technologies Inc. (Novadaq) is a medical imaging company. It develops, manufactures and markets real-time fluorescence imaging technology products. The company’s SPY Imaging Technology products include SPY Elite open surgical imaging system, PinPoint endoscopic fluorescence imaging s …
  • Option NV (OPTI):企業の財務・戦略的SWOT分析
    Option NV (OPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Latvenergo AS:電力:M&Aディール及び事業提携情報
    Summary Latvenergo AS (Latvenergo) is a state-owned power supply utility company that generates and supplies electricity and thermal energy, distributes electricity, leases transmission system assets. It generates electricity through various renewable energy sources such as hydropower, biomass, wind …
  • Medigard Ltd (MGZ):医療機器:M&Aディール及び事業提携情報
    Summary Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd, is a medical device company that designs and develops retractable safety medical devices. The company provides products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and …
  • Iron Mountain Incorporated:企業のM&A・事業提携・投資動向
    Iron Mountain Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iron Mountain Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Xylem Inc (XYL)-エネルギー分野:企業M&A・提携分析
    Summary Xylem Inc. (Xylem) is a water technology company that designs, manufactures, and service engineered technologies for water industry. The company’s products portfolio includes testing equipment; filtration, disinfection and biological treatment equipment; controls and systems; and water and w …
  • Owens & Minor Inc (OMI)-製薬・医療分野:企業M&A・提携分析
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …
  • NPO Petrovax Pharm LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NPO Petrovax Pharm LLC (Petrovax) focuses on the research, development and manufacturing of medicines and vaccines. The company’s expertise spans in producing APIs and liquid, semi-solid, and solid dosage forms in ampoules, plastic containers, vials and disposable syringes. It also provides …
  • AusGroup Ltd (5GJ):企業の財務・戦略的SWOT分析
    Summary AusGroup Ltd (AusGroup) is a provider of project and asset services. The company operates through its subsidiaries, namely, MAS, AGC, and NT Port and Marine. Its major services include mechanical and piping, scaffolding, multidisciplinary maintenance services, fabrication & management, elect …
  • Desjardins Financial Security Life Assurance Company:企業の戦略・SWOT・財務情報
    Desjardins Financial Security Life Assurance Company - Strategy, SWOT and Corporate Finance Report Summary Desjardins Financial Security Life Assurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Efora Energy Ltd (EEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Efora Energy Ltd (Efora Energy), formerly SacOil Holdings Ltd, a subsidiary of Public Investment Corp Ltd, is an independent oil and gas exploration and production company that acquires, explores, develops and produces hydrocarbon assets in Africa. The company holds a diverse portfolio of as …
  • Ophthotech Corp (OPHT):企業の財務・戦略的SWOT分析
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt disease. It also provides Fovista, a …
  • Tilaknagar Industries Ltd:企業の戦略・SWOT・財務分析
    Tilaknagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Tilaknagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Uni-Select Inc.:企業のM&A・事業提携・投資動向
    Uni-Select Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Uni-Select Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Nelnet, Inc.:企業のM&A・事業提携・投資動向
    Nelnet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nelnet, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Carl Zeiss Meditec AG (AFX)-医療機器分野:企業M&A・提携分析
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of ey …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆